Myeloproliferative Neoplasms tests in Dubai & UAE

Compare available Myeloproliferative Neoplasms tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,800.00–3,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Myeloproliferative Neoplasms test prices

Showing 1–3 of 3 matching tests.

Myeloproliferative Neoplasms diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1978 JAK2 Somatic Mutation Analysis (Myelofibrosis) Test This test identifies somatic mutations in the JAK2 gene, which are key drivers in myelofibrosis and related blood disorders.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["JAK2 gene somatic mutations", "V617F mutation", "Other JAK2 mutation hotspots"] Parameters [] Preparation ["No fasting required", "No special preparation needed"] Indications ["Suspected myelofibrosis", "Diagnosis of myeloproliferative neoplasms", "Guiding targeted therapy"] Measurement technique Confirm with laboratory Codes LOINC: 42821-9 ICD-10: D47.1 Clinical summary This test identifies somatic mutations in the JAK2 gene, which are key drivers in myelofibrosis and related blood disorders.
TEST-1916 JAK2 V617F Mutation Analysis (Somatic) by NGS Test This test detects the somatic JAK2 V617F mutation in blood or DNA samples using Next-Generation Sequencing.	Whole blood (EDTA) or extracted DNA	14–21 business days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["JAK2 V617F mutation", "Allele frequency"] Parameters [{"name": "JAK2 V617F Mutation Status", "reference_range": "Negative / Positive"}, {"name": "Allele Frequency (VAF)", "reference_range": "Reported as percentage (e.g., 1%, 5%, 10%...)"}] Preparation ["Avoid aspirin, NSAIDs, or herbal supplements for 48 hours before collection", "Inform the phlebotomist about all current medications"] Indications ["Diagnosis of polycythemia vera", "Diagnosis of essential thrombocythemia", "Diagnosis of primary myelofibrosis", "Monitoring minimal residual disease"] Measurement technique Confirm with laboratory Codes LOINC: 39380-3 ICD-10: D45, D47.3, D47.1 Clinical summary This test detects the somatic JAK2 V617F mutation in blood or DNA samples using Next-Generation Sequencing.
TEST-2613 Myeloproliferative Neoplasm with Eosinophilia (MPN-Eo) Test This test evaluates for specific gene rearrangements (PDGFRA, PDGFRB, FGFR1, JAK2) associated with Myeloproliferative Neoplasm with Eosinophilia (MPN-Eo) using FISH and morphology.	Peripheral Blood & Bone Marrow Aspirate / Biopsy	7 working days	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Gene rearrangements in PDGFRA", "Gene rearrangements in PDGFRB", "Gene rearrangements in FGFR1", "Gene rearrangements in JAK2", "Bone marrow morphology", "Peripheral blood cell counts"] Parameters [] Preparation ["A fully completed Chromosome & FISH Analysis Requisition Form (Form 17) is mandatory before sample collection."] Indications ["Suspicion of Myeloproliferative Neoplasm with Eosinophilia (MPN-Eo)", "Evaluation for targeted tyrosine kinase inhibitor therapy"] Measurement technique Confirm with laboratory Codes LOINC: 48768-6 ICD-10: D47.2, D72.1 Clinical summary This test evaluates for specific gene rearrangements (PDGFRA, PDGFRB, FGFR1, JAK2) associated with Myeloproliferative Neoplasm with Eosinophilia (MPN-Eo) using FISH and morphology.

Category overview

Myeloproliferative Neoplasms: overview

Dealing with an unexplained overproduction of red cells, white cells, or platelets requires precise molecular insights to prevent severe cardiovascular complications and manage your vitality. As an advanced subspecialty within our Hematology and Genetics services, testing for Myeloproliferative Neoplasms (MPNs) evaluates your blood and bone marrow for specific genetic drivers, such as JAK2 or CALR mutations. By leveraging state-of-the-art sequencing technology, this highly focused screening helps confirm conditions like polycythemia vera or essential thrombocythemia, offering the definitive data needed to safely guide highly personalized medical treatments and targeted blood-thinning therapies. Highly regarded for complex molecular analysis among top diagnostic labs in Dubai and the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical accuracy, and incredibly efficient reporting. Restore your hematological stability—book your myeloproliferative neoplasms testing in UAE, arrange a secure clinical sample collection, or consult our dedicated hematology experts today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.